Bulletin
Investor Alert

Evolent Health Inc. Cl A

NYS: EVH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 14, 2020, 7:44 p.m.

EVH
/zigman2/quotes/207127728/composite

$

12.65

Change

+0.04 +0.32%

Volume

Volume 12,448

Quotes are delayed by 20 min

/zigman2/quotes/207127728/composite

Previous close

$ 14.02

$ 12.61

Change

-1.41 -10.06%

Day low

Day high

$12.21

$13.82

Open

52 week low

52 week high

$3.50

$14.02

Open

Company Description

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technol...

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Valuation

Price to Sales Ratio

0.88

Price to Book Ratio

0.83

Enterprise Value to Sales

1.18

Total Debt to Enterprise Value

0.37

Efficiency

Revenue/Employee

248,936.00

Income Per Employee

-88,815.00

Receivables Turnover

10.60

Total Asset Turnover

0.51

Liquidity

Current Ratio

1.19

Quick Ratio

1.19

Cash Ratio

0.64

Profitability

Gross Margin

16.03

Operating Margin

-12.17

Pretax Margin

-38.65

Net Margin

-35.68

Return on Assets

-18.06

Return on Equity

-29.23

Return on Total Capital

-7.61

Return on Invested Capital

-22.79

Capital Structure

Total Debt to Total Equity

39.98

Total Debt to Total Capital

28.56

Total Debt to Total Assets

22.75

Long-Term Debt to Equity

39.30

Long-Term Debt to Total Capital

28.08

Officers and Executives

Name Age Officer Since Title
Mr. Frank J. Williams 51 2011 Chairman & Chief Executive Officer
Mr. Seth B. Blackley 39 2011 President
Mr. Steven Tutewohl - 2020 Chief Operating Officer
Mr. John Johnson 35 2019 Chief Financial Officer
Dr. Jamie Sharp - -

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/05/2020 Jonathan D. Weinberg
General Counsel
10,000   Disposition at $13.01 per share. 130,100
08/05/2020 Jonathan D. Weinberg
General Counsel
10,000   Derivative/Non-derivative trans. at $3.84 per share. 38,400
06/09/2020 Michael A. D'Amato
Director
18,302   Award at $0 per share. 0
06/09/2020 Bruce C. Felt
Director
18,302   Award at $0 per share. 0
06/09/2020 Diane P. Holder
Director
18,302   Award at $0 per share. 0
06/09/2020 David M. Farner
Director
18,302   Award at $0 per share. 0
06/09/2020 Cheryl M. Scott
Director
18,302   Award at $0 per share. 0
06/09/2020 Mary Bridget Duffy
Director
18,302   Award at $0 per share. 0
06/09/2020 Peter Grua
Director
18,302   Award at $0 per share. 0
03/02/2020 John Johnson
Chief Financial Officer
80,000   Award at $0 per share. 0
03/02/2020 Jonathan D. Weinberg
General Counsel
40,000   Award at $0 per share. 0
03/02/2020 Lydia Stone
Chief Accounting Officer
25,000   Award at $0 per share. 0
02/03/2020 Peter Grua
Director
5,219   Award at $0 per share. 0
12/04/2019 Seth B. Blackley
President; Director
14,749   Acquisition at $6.73 per share. 99,260
12/03/2019 Frank J. Williams
Chief Executive Officer; Director
35,000   Acquisition at $6.51 per share. 227,850
08/15/2019 Kenneth A. Samet
Director
7,200   Acquisition at $7.04 per share. 50,688
08/09/2019 Michael A. D'Amato
Director
15,000   Acquisition at $7.03 per share. 105,450
06/11/2019 Michael A. D'Amato
Director
14,156   Award at $0 per share. 0
06/11/2019 Bruce C. Felt
Director
14,156   Award at $0 per share. 0
06/11/2019 Diane P. Holder
Director
14,156   Award at $0 per share. 0
06/11/2019 David M. Farner
Director
14,156   Award at $0 per share. 0
06/11/2019 Cheryl M. Scott
Director
14,156   Award at $0 per share. 0
06/11/2019 Mary Bridget Duffy
Director
14,156   Award at $0 per share. 0
06/11/2019 Kenneth A. Samet
Director
14,156   Award at $0 per share. 0
03/11/2019 Michael A. D'Amato
Director
10,000   Acquisition at $12.45 per share. 124,500
/news/latest/company/us/evh

MarketWatch News on EVH

  1. Evolent Health downgraded to sector weight from overweight at KeyBanc Capital

    6:22 a.m. July 6, 2020

    - Tomi Kilgore

  2. Evolent Health price target lowered to $12 from $16 at SunTrust

    7:25 a.m. March 26, 2020

    - Emily Bary

  3. Carnival’s Ship Could Come In Next Year

    10:30 p.m. Dec. 27, 2019

    - Barron's Online

  4. Evolent Health maintained as buy with $16 price target at Canaccord

    11:49 a.m. Dec. 24, 2019

    - Ciara Linnane

  5. Evolent Health reiterated as overweight at KeyBanc

    8:16 a.m. Dec. 24, 2019

    - Ciara Linnane

  6. Evolent Health stock price target cut to $14 from $17 at SunTrust RH

    8:52 a.m. Dec. 4, 2019

    - Tomi Kilgore

  7. Evolent Health stock price target cut to $10 from $20 at KeyBanc Capital

    9:06 a.m. Dec. 2, 2019

    - Tomi Kilgore

  8. Evolent Health stock price target cut to $17 vs. $19 at SunTrust Robinson Humphrey

    8:03 a.m. May 31, 2019

    - Ciara Linnane

  9. A New Era of Tech Holds Promise for Health Records

    3:30 p.m. May 20, 2019

    - Barron's Online

  10. Evolent Health stock price target cut to $20 from $32 at KeyBanc Capital

    10:23 a.m. March 4, 2019

    - Tomi Kilgore

  11. Evolent Health downgraded to neutral from overweight at J.P. Morgan

    7:19 a.m. April 24, 2018

    - Tomi Kilgore

  12. Evolent Health stock price target cut to $27 from $32 at Canaccord Genuity

    11:30 a.m. Dec. 12, 2017

    - Tomi Kilgore

  13. Stocks to Play Health Care’s Transformation

    9:34 a.m. Sept. 22, 2017

    - Barron's Online

  14. Barron’s Roundtable, Part 3: Digging Into the Details

    1:03 p.m. Jan. 30, 2017

    - Barron's Online

  15. Evolent Health started at outperform with $16 stock price target at FBR & Co.

    9:05 a.m. March 29, 2016

    - Tomi Kilgore

/news/nonmarketwatch/company/us/evh

Other News on EVH

  1. 10-Q: EVOLENT HEALTH, INC.

    6:39 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. Chegg (CHGG) to Report Q2 Earnings: What's in the Offing?

    12:18 p.m. July 29, 2020

    - Zacks.com

  3. MYOV, NBRV, RWLK and WWR among midday movers

    12:43 p.m. June 1, 2020

    - Seeking Alpha

  4. EVH, PFE among premarket losers

    9:21 a.m. June 1, 2020

    - Seeking Alpha

  5. Evolent comes up empty on Kentucky Medicaid contract

    11:36 a.m. May 30, 2020

    - Seeking Alpha

  6. 10-Q: EVOLENT HEALTH, INC.

    6:06 a.m. May 28, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  7. Evolent debt financing sufficient to close Passport buy - Piper

    1:09 p.m. Dec. 31, 2019

    - Seeking Alpha

  8. Loading more headlines...

At a Glance

Evolent Health, Inc.

800 North Glebe Road

Suite 500

Arlington, Virginia 22203

Phone

1 5713896000

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$846.38M

Net Income

$-301.97M

2019 Sales Growth

35.0%

Employees

3,400

/news/pressrelease/company/us/evh

Press Releases on EVH

  1. US Stocks Indicating Bullish Trend: $DRIO $EVH $YNDX

    8:20 a.m. Aug. 6, 2020

    - The Market Signal

  2. Evolent Health Announces Second Quarter 2020 Results

    4:02 p.m. Aug. 4, 2020

    - PR Newswire - PRF

  3. Evolent Health to Participate in Upcoming Investor Conference

    9:37 a.m. Aug. 3, 2020

    - PR Newswire - PRF

  4. Loading more headlines...
Link to MarketWatch's Slice.